A second study showed that the recently approved drug Ipilimumab, sold under the name Yervoy, also extends survival for melanoma patients with advanced disease.
第二項研究顯示Ipilimumab(商品名為Yervoy)也能延長有合併症的黑*素瘤患者生存率。